Membranes of herpes simplex virus type-1-infected human corneal epithelial cells are not permeabilized to macromolecules and therefore do not release 1l-1α

Virology

Volumn 244, Issue 1, 1998, Pages 74-78

  Tran, Mau T ^a   Dean, David A ^a   Lausch, Robert N ^a   Oakes, John E ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA;

ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOKINE PRODUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TRANSMISSION;

HERPES; HUMAN HERPESVIRUS 1; RNA VIRUSES;

EID: 0032565357     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9084     Document Type: Article

References (36)

1. Adam S. A., Sterne-Marr R., Gerace L. Nuclear protein import in permeabilized mammalian cells requires cytoplasmic factors. J. Cell Biol. 111:1990;807-816.
2. Agace W., Hedges S., Andersson U., Andersson J., Ceska M., Svanborg C. Selective cytokine production by epithelial cells following exposure toEscherichia coli. Infect. Immun. 61:1993;602-609.
3. Bakouche O., Brown D. C., Lachman L. B. Subcellular localization of human monocyte Interleukin 1: Evidence for an inactive precursor molecule and a possible mechanism for IL 1 release. J. Immunol. 138:1987;4249-4255.
4. Banfield B. W., Tufaro F. Herpes simplex virus particles are unable to traverse the secretory pathway in the mouse L-cell mutant gro29. J. Virol. 64:1990;5716-5729.
5. Cserpán I., Udvardy A. The mechanism of nuclear transport of natural or artificial transport substrates in digitonin-permeabilized cells. J. Cell. Sci. 108:1995;1849-1861.
6. Cubitt C. L., Tang Q., Monterio C. A., Lausch R. N., Oakes J. E. IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci. 34:1993;3199-3206.
7. Davson H. The cornea. Physiology of the Eye. 1990;Pergamon, Elmsforth. p. 105-130.
8. Dinarello C. A. Interleukin-1. Adv. Pharmacol. 25:1994a;21-51.
9. Dinarello C. A. The interleukin-1 family: 10 years of discovery. Fed. Am. Soc. Exp. Biol. J. 8:1994b;1314-1325.
10. Dustin M. L., Rothlein R., Bhan A. K., Dinarello C. A., Springer T. A. Induction by IL 1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:1986;245-254.
11. Eckmann L., Reed S. L., Smith J. R., Kagnoff M. F. Entamoeba histolyticatrophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released Interleukin-1α J. Clin. Invest. 96:1995;1269-1279.
12. Fraser N. W., Spivack J. G., Wroblewska Z., Block T., Deshmane S. L., Valyi-Nagy T., Natarajan R., Gesser R. A review of the mechanism of HSV latency. Curr. Eye Res. 10:1991;1-13.
13. Furie M. B., Randolph G. J. Chemokines and tissue injury. Am. J. Pathol. 146:1995;1287-1301.
14. Gahring L. C., Buckley A., Daynes R. A. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J. Clin. Invest. 76:1985;1585-1591.
15. Groves R. W., Ross E., Barker J. N. W. N., Ross J., Camp C. D. R., MacDonald D. M. Effect of in vivo interleukin 1 on adhesion molecule expression in normal human skin. J. Invest. Dermatol. 98:1992;384-387.
16. Hauser C., Saurat J.-H., Schmitt A., Jaunin F., Dayer J.-M. Interleukin 1 is present in normal human epidermis. J. Immunol. 136:1986;3317-3321.
17. Hendricks R. L., Tumpey T. Contribution of virus and immune factors to herpes simplex virus type 1-induced corneal pathology. Invest. Ophthalmol. Vis. Sci. 31:1990;1929-1939.
18. Johnson D. C., Spear P. G. Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J. Virol. 43:1982;1102-1112.
19. Kameda K., Sato K. Regulation of IL-1α expression in human keratinocytes: Transcriptional activation of the IL-1α gene by TNF-α, LPS and IL-1α Lymphokine Cytokine Res. 13:1994;29-35.
20. Kupper T. S., Ballard D. W., Chua A. O., McGuire J. S., Flood P. M., Horowitz M. C., Langdon R. C., Lightfoot L., Gubler U. Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1α and α mRNA. J. Exp. Med. 164:1986;2095-2210.
21. Matushima K., Taguchi M., Kovacs E. J., Young H. A., Oppenheim J. J. Intracellular localization of human monocytes associated interleukin 1 (IL 1) activity and release of biologically IL 1 from monocytes by trypsin and plasmin. J. Immunol. 136:1986;2883-2891.
22. Metcalf J. F., Kaufman H. E. Herpetic stromal keratitis: Evidence for cell mediated immunopathogenesis. Am. J. Ophthalmol. 82:1976;827-834.
23. Meyers R. L., Pettit T. H. Chemotaxis of polymorphonuclear leukocytes in corneal inflammation: Tissue injury in herpes simplex virus infection. Invest. Ophthalmol. Vis. Sci. 13:1974;187-197.
24. Meyers-Elliott R. H., Chitjian P. A. Immunopathogenesis of corneal inflammation in herpes simplex virus stromal keratitis: Role of the polymorphonuclear leukocyte. Invest. Ophthalmol. Vis. Sci. 20:1981;784-798.
25. Oakes J. E., Monterio C. A., Cubitt C. L., Lausch R. N. Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells. J. Virol. 67:1993;4777-4784.
26. Pepose J. S. Herpes simplex keratitis: Role of viral infection versus immune response. Surveys Ophthalmol. 35:1991;345-352.
27. Pepose J. S., Holland G. N., Wilhelmus K. Ocular Infection and Immunity. 1996;Mosby, St. Louis.
28. Rasmussen S. J., Eckmann L., Qyayle A. J., Shen L., Zhang Y.-X., Anderson D. J., Fierer J., Stephens R. S., Kagnoff M. F. Secretion of proinflammatory cytokines by epithelial cells in response toChlamydiainfection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 99:1997;77-87.
29. Roizman B., Sears A. E. Herpes simplex virus and their replication. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 2231-2295.
30. Sauder D. N., Carter C. S., Katz S. I., Oppenheim J. J. Epidermal cell production of thymocyte activating factor (ETAF). J. Invest. Dermatol. 79:1982;34-39.
31. Stevenson F. T., Torrano F., Locksley R. M., Lovett D. H. Interleukin 1: The patterns of translation and intracellular distribution support alternative secretory mechanisms. J. Cell. Physiol. 152:1992;223-231.
32. Strieter R. M., Standiford T. J., Huffnagle G. B., Colletti L. M., Lukacs N. W., Kunkel S. L. "The Good, the Bad, and the Ugly": The role of chemokines in models of human disease. J. Immunol. 156:1996;3583-3586.
33. Strober W., Coligan J. E., Kruisbeek A., Margulies D. H., Shevach E. M. Current Protocols in Immunology, Vol. III, Trypan Blue Exclusion Test of Cell Viability. 1997;Wiley, New York. p. A.3B.1-A.3.B.2.
34. Thomas J., Gangappa S., Kanangat S., Rouse B. T. On essential involvement of neutrophils in the immunopathologic disease: Herpetic stromal keratitis. J. Immunol. 158:1997;1383-1391.
35. Walters C. E., Ingham E., Eady E. A., Cove J. H., Kearney J. N., Cunliffe W. J. In vitro modulation of keratinocyte-derived interleukin-1α (IL-1α) and peripheral blood mononuclear cell-derived IL-1α release in response to cutaneous commensal microorganisms. Infect. Immun. 63:1995;1223-1228.
36. Walz G., Arutfo A., Kolanus W., Bevilacqua M., Seed B. Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science. 250:1990;1132-1135.